Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: With the recent increase in the number of drug therapy options for unresectable hepatocellular carcinoma (u-HCC), the key issue has become how to prolong overall survival (OS). The aim was to evaluate the association between radiological response and OS in patients treated with lenva...

Descripción completa

Detalles Bibliográficos
Autores principales: Amioka, Kei, Kawaoka, Tomokazu, Kosaka, Masanari, Johira, Yusuke, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Fujii, Yasutoshi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Masaki, Keiichi, Honda, Yoji, Kouno, Hirotaka, Kohno, Hiroshi, Moriya, Takashi, Naeshiro, Noriaki, Nonaka, Michihiro, Hyogo, Hideyuki, Aisaka, Yasuyuki, Azakami, Takahiro, Hiramatsu, Akira, Aikata, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774012/
https://www.ncbi.nlm.nih.gov/pubmed/35053484
http://dx.doi.org/10.3390/cancers14020320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774012/
https://www.ncbi.nlm.nih.gov/pubmed/35053484
http://dx.doi.org/10.3390/cancers14020320

Ejemplares similares